FDA Approves First Gene Therapy to Treat Adults with Metastatic Synovial Sarcoma

Estimated reading time: 1 minutes

• About The Author

FDA approves Tecelra, a gene therapy to treat adults with unresectable or metastatic synovial sarcoma. Tecelra is also the first FDA-approved T cell receptor (TCR) gene therapy.

About The Author

See author's posts

Trending

Google Ranking Factors and Marketing KPIs